APA

Rowbottom M. W., Faraoni R., Chao Q., Campbell B. T., Lai A. G., Setti E., Ezawa M., Sprankle K. G., Abraham S., Tran L., Struss B., Gibney M., Armstrong R. C., Gunawardane R. N., Nepomuceno R. R., Valenta I., Hua H., Gardner M. F., Cramer M. D., Gitnick D., Insko D. E., Apuy J. L., Jones-Bolin S., Ghose A. K., Herbertz T., Ator M. A., Dorsey B. D., Ruggeri B., Williams M., Bhagwat S., James J. & Holladay M. W. (20120423). Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E. : Journal of medicinal chemistry.

Chicago

Rowbottom Martin W, Faraoni Raffaella, Chao Qi, Campbell Brian T, Lai Andiliy G, Setti Eduardo, Ezawa Maiko, Sprankle Kelly G, Abraham Sunny, Tran Lan, Struss Brian, Gibney Michael, Armstrong Robert C, Gunawardane Ruwanthi N, Nepomuceno Ronald R, Valenta Ianina, Hua Helen, Gardner Michael F, Cramer Merryl D, Gitnick Dana, Insko Darren E, Apuy Julius L, Jones-Bolin Susan, Ghose Arup K, Herbertz Torsten, Ator Mark A, Dorsey Bruce D, Ruggeri Bruce, Williams Michael, Bhagwat Shripad, James Joyce and Holladay Mark W. 20120423. Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E. : Journal of medicinal chemistry.

Harvard

Rowbottom M. W., Faraoni R., Chao Q., Campbell B. T., Lai A. G., Setti E., Ezawa M., Sprankle K. G., Abraham S., Tran L., Struss B., Gibney M., Armstrong R. C., Gunawardane R. N., Nepomuceno R. R., Valenta I., Hua H., Gardner M. F., Cramer M. D., Gitnick D., Insko D. E., Apuy J. L., Jones-Bolin S., Ghose A. K., Herbertz T., Ator M. A., Dorsey B. D., Ruggeri B., Williams M., Bhagwat S., James J. and Holladay M. W. (20120423). Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E. : Journal of medicinal chemistry.

MLA

Rowbottom Martin W, Faraoni Raffaella, Chao Qi, Campbell Brian T, Lai Andiliy G, Setti Eduardo, Ezawa Maiko, Sprankle Kelly G, Abraham Sunny, Tran Lan, Struss Brian, Gibney Michael, Armstrong Robert C, Gunawardane Ruwanthi N, Nepomuceno Ronald R, Valenta Ianina, Hua Helen, Gardner Michael F, Cramer Merryl D, Gitnick Dana, Insko Darren E, Apuy Julius L, Jones-Bolin Susan, Ghose Arup K, Herbertz Torsten, Ator Mark A, Dorsey Bruce D, Ruggeri Bruce, Williams Michael, Bhagwat Shripad, James Joyce and Holladay Mark W. Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E. : Journal of medicinal chemistry. 20120423.